Skip to main content

Table 3 Patient backgrounds, categorical variables

From: RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale

Number of cases

Double dose of statin

Statin + ezetimibe

p value

  

n = 56

n = 53

Male

%

57.1

58.5

0.887

Smoking

%

23.6

25.0

0.869

Family history of CAD

%

9.3

9.6

0.950

Hypertension

%

67.9

58.5

0.311

Hypertriglyceridemia

%

34.5

41.5

0.456

CKD

%

16.1

9.4

0.301

Low HDL-C

%

3.6

7.5

0.363

History of stroke

%

3.6

0.0

0.169

History of CAD

%

10.7

15.1

0.495

  1. The data were assessed using the χ2-test. CAD: coronary artery disease.